Petros Pharmaceuticals to Present at the Q1 Investor Summit Conference

Rhea-AI Summary

Petros Pharmaceuticals, a leader in men's health therapeutics, announced that President Fady Boctor will present a corporate overview at the Q1 Investor Summit Conference on March 9, 2022, at 2:00 PM ET. This virtual event will allow attendees to learn about the company’s initiatives in addressing men's health issues, including erectile dysfunction and Peyronie's disease. Boctor will also be available for one-on-one meetings throughout the conference. Interested parties can register for the summit online.

For more information, visit their registration page.

News Market Reaction

-2.21%

1 alert

-2.21% News Effect

On the day this news was published, PTPI declined 2.21%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Q1 Investor Summit Conference, which is being held virtually on March 8 – 9, 2022.

Mr. Boctor will deliver his corporate presentation on Wednesday, March 9
at 2:00 PM ET.

Mr. Boctor will be available for one-on-one meetings throughout the conference.

Click here to register: Q1 Investor Summit - INVESTOR REGISTRATION

About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.

CONTACTS:
Jules Abraham
CORE IR
917-885-7378
pr@coreir.com

FAQ

What is the date and time of Petros Pharmaceuticals' presentation at the Q1 Investor Summit?

Petros Pharmaceuticals' President Fady Boctor will present on March 9, 2022, at 2:00 PM ET.

Where can I register for the Q1 Investor Summit featuring Petros Pharmaceuticals?

You can register for the Q1 Investor Summit online through the provided registration page link.

What topics will Petros Pharmaceuticals discuss at the Q1 Investor Summit?

Petros Pharmaceuticals will focus on their initiatives in men's health, including erectile dysfunction and Peyronie's disease.

Is there an opportunity for one-on-one meetings with Petros Pharmaceuticals at the conference?

Yes, Fady Boctor will be available for one-on-one meetings throughout the conference.

What is the significance of the Q1 Investor Summit for Petros Pharmaceuticals?

The Q1 Investor Summit provides Petros Pharmaceuticals a platform to present their corporate overview and engage with investors about their men's health therapeutics.